Current evidence suggests that GLP-1 medications, when used with appropriate patient selection and monitoring, likely do not pose significant long-term threats to vision for most patients and may contribute to better overall ocular outcomes through improved metabolic control
Clinical trials demonstrated that Ozempic produced statistically notable reductions in hemoglobin A1c levels compared to placebo and other diabetes medications, with the added benefit of body weight reduction as a secondary outcome
Nutrition determines what that reduced appetite is doing for your body
Adequate protein intake supports skin integrity, while vitamins A, C, E, and essential fatty acids contribute to skin health
Your provider may recommend clinically-backed options like GLP-1 medications as part of your plan
Convenient Convenient care, right from your phone no waiting rooms, no hassle